INTRODUCTION: Altitude decompression sickness (DCS) that involves the central nervous system (CNS) is a rare but potentially serious condition. Identification of early symptoms and signs of this condition might improve treatment. METHODS: We studied data from 26 protocols carried out in our laboratory over the period 1983-2003; all were designed to provoke DCS in a substantial proportion of subjects. The data set included 2843 cases. We classified subject-exposures that resulted in DCS as: 1) neurological DCS of peripheral and/or central origin (NEURO); 2) a subset of those that involved only the CNS (CNS); and 3) all other cases, i.e., DCS cases that did not have a neurological component (OTHER). For each case, echo imaging data were used to document whether venous gas emboli (VGE) were present, and their level was classified as: 1) any level, i.e., Grade 1 or higher (VGE-1); and 2) high level, Grade 4 (VGE-4). RESULTS: There were 1108 cases of altitude DCS in the database; 218 were classified as NEURO and 49 of those as CNS. VGE-1 were recorded in 83.8% of OTHER compared with 58.7% of NEURO and 55.1% of CNS (both p < 0.001 compared with OTHER). The corresponding values for VGE-4 were 48.8%, 37.0%, and 34.7% (p < 0.001, compared to OTHER). Hyperbaric oxygen (HBO) was used to treat about half of the CNS cases, while all other cases were treated with 2 h breathing 100% oxygen at ground level. DISCUSSION: Since only about half of the rare cases of hypobaric CNS DCS cases were accompanied by any level of VGE, echo imaging for bubbles may have limited application for use as a predictor of such cases.
INTRODUCTION: Altitude decompression sickness (DCS) that involves the central nervous system (CNS) is a rare but potentially serious condition. Identification of early symptoms and signs of this condition might improve treatment. METHODS: We studied data from 26 protocols carried out in our laboratory over the period 1983-2003; all were designed to provoke DCS in a substantial proportion of subjects. The data set included 2843 cases. We classified subject-exposures that resulted in DCS as: 1) neurological DCS of peripheral and/or central origin (NEURO); 2) a subset of those that involved only the CNS (CNS); and 3) all other cases, i.e., DCS cases that did not have a neurological component (OTHER). For each case, echo imaging data were used to document whether venous gas emboli (VGE) were present, and their level was classified as: 1) any level, i.e., Grade 1 or higher (VGE-1); and 2) high level, Grade 4 (VGE-4). RESULTS: There were 1108 cases of altitude DCS in the database; 218 were classified as NEURO and 49 of those as CNS. VGE-1 were recorded in 83.8% of OTHER compared with 58.7% of NEURO and 55.1% of CNS (both p < 0.001 compared with OTHER). The corresponding values for VGE-4 were 48.8%, 37.0%, and 34.7% (p < 0.001, compared to OTHER). Hyperbaric oxygen (HBO) was used to treat about half of the CNS cases, while all other cases were treated with 2 h breathing 100% oxygen at ground level. DISCUSSION: Since only about half of the rare cases of hypobaric CNS DCS cases were accompanied by any level of VGE, echo imaging for bubbles may have limited application for use as a predictor of such cases.
Entities:
Keywords:
NASA Discipline Environmental Health; Non-NASA Center
Authors: Jennifer A McGuire; Paul M Sherman; Erica Dean; Jeremy M Bernot; Laura M Rowland; Stephen A McGuire; Peter V Kochunov Journal: Mil Med Date: 2017-05 Impact factor: 1.437
Authors: Stephen A McGuire; Meghann C Ryan; Paul M Sherman; John H Sladky; Laura M Rowland; S Andrea Wijtenburg; L Elliot Hong; Peter V Kochunov Journal: Hum Brain Mapp Date: 2019-03-29 Impact factor: 5.038
Authors: Stephen A McGuire; David F Tate; Joe Wood; John H Sladky; Kent McDonald; Paul M Sherman; Elaine S Kawano; Laura M Rowland; Beenish Patel; Susan N Wright; Elliot Hong; Jennifer Rasmussen; Adam M Willis; Peter V Kochunov Journal: Neurology Date: 2014-07-09 Impact factor: 9.910
Authors: Stephen A McGuire; Goldie R E Boone; Paul M Sherman; David F Tate; Joe D Wood; Beenish Patel; George Eskandar; S Andrea Wijtenburg; Laura M Rowland; Geoffrey D Clarke; Patrick M Grogan; John H Sladky; Peter V Kochunov Journal: Aerosp Med Hum Perform Date: 2016-12-01 Impact factor: 1.053
Authors: Diego Iacono; Erin K Murphy; Paul M Sherman; Holly Chapapas; Bianca Cerqueira; Christine Christensen; Daniel P Perl; John Sladky Journal: Sci Rep Date: 2022-04-27 Impact factor: 4.996
Authors: Stephen A McGuire; Paul M Sherman; Anthony C Brown; Andrew Y Robinson; David F Tate; Peter T Fox; Peter V Kochunov Journal: Aviat Space Environ Med Date: 2012-12
Authors: Stephen McGuire; Paul Sherman; Leonardo Profenna; Patrick Grogan; John Sladky; Anthony Brown; Andrew Robinson; Laura Rowland; Elliot Hong; Beenish Patel; David Tate; Elaine S Kawano; Peter Fox; Peter Kochunov Journal: Neurology Date: 2013-08-20 Impact factor: 9.910